MSB 3.21% $1.13 mesoblast limited

Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-63

  1. 17,007 Posts.
    lightbulb Created with Sketch. 2411
    The obfuscation is quite deliberate. They want to make an announcement that the market that tells partial truths to avoid disappointing the market.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.